Cas:1313712-32-1 1H-pyrido[2,3-b][1,4]oxazin-2-ol manufacturer & supplier

We serve Chemical Name:1H-pyrido[2,3-b][1,4]oxazin-2-ol CAS:1313712-32-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

1H-pyrido[2,3-b][1,4]oxazin-2-ol

Chemical Name:1H-pyrido[2,3-b][1,4]oxazin-2-ol
CAS.NO:1313712-32-1
Synonyms:qc-8730
Molecular Formula:C7H6N2O2
Molecular Weight:150.13500
HS Code:2934999090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:54.38000
Exact Mass:150.04300
LogP:1.38080

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like qc-8730 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,qc-8730 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,qc-8730 Use and application,qc-8730 technical grade,usp/ep/jp grade.


Related News: China has a complete upstream and downstream industry chain, lower costs, and good talent reserves. It is one of the few industries in China that has an advantage in international competition. 1H-pyrido[2,3-b][1,4]oxazin-2-ol manufacturer Secretary of Health Francisco Duque said authorities are working with the Chinese embassy to respectfully handle the remains of the man while following international protocol to contain the disease. 1H-pyrido[2,3-b][1,4]oxazin-2-ol supplier In addition, the FDA approval ignored the recommendation of its outside advisors, who said Biogen did not provide enough evidence of clinical benefit. Three of the advisory panel’s members have resigned in protest since the FDA decision was announced on Monday. 1H-pyrido[2,3-b][1,4]oxazin-2-ol vendor An effective treatment for Alzheimer��s, which is estimated in 60%-70% of around 50 million dementia cases worldwide, could become one of the best-selling drugs globally. 1H-pyrido[2,3-b][1,4]oxazin-2-ol factory Under the sub-licensing agreement, Mankind will market the drug under its own trademark while Glenmark will manufacture and supply it to the drug firm.